← All stocks

BlossomHill Therapeutics, Inc.

BLSM No buying or selling

CIK 0001839970 #3158 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Chen Bihua

Director

—

3,614,034

$57.82M

—

ORBIMED ADVISORS LLC entity

Director

—

2,714,279

$43.43M

—

GORDON CARL L

Director

—

2,714,279

$43.43M

—

Agrawal Sundeep

Director

—

578,524

$9.26M

—

Liptak Vincent Paul

General Counsel

—

134,099

$2.15M

+25.7%

Li Yishan

Executive Chairman

—

124,779

$2.00M

—

Cui Jingrong Jean

President and CEO

—

124,779

$2.00M

—

Schmid John P.

Director

—

6,000

$96.00K

—

Keyes Jason A

Chief Financial Officer

—

700

$11.20K

—

No percentages here. BlossomHill Therapeutics, Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 10 Aug 2026